Targeted Therapy
Brand names:
Xalkori®
Often used for:
Lung cancer
Crizotinib is a type of medicine called a targeted therapy. This medicine is a tyrosine kinase inhibitor. It acts to block certain cell signals to help keep cells from growing. Crizotinib is used to treat non-small cell lung cancer that is anaplastic lymphoma kinase (ALK) or ROS1 positive.
Patients will have regular blood draws to check blood counts and monitor liver and kidney function.
May be taken as a capsule by mouth
Not all patients who take crizotinib will experience these side effects. Common side effects are in bold, but there may be others. Please report all suspected side effects to your doctor or pharmacist.
Be sure to discuss these and other recommendations with your doctor or pharmacist.